Global Mammalian Single Cell Analysis Market Size, Trends & Analysis - Forecasts to 2026 By Components (Instruments [NGS systems, Flow Cytometer, PCR, Spectrophotometer, Microarray and Others], Consumables & Reagents and Software), By Application (Cell Interaction Study, Toxicity Study, Gene Therapy Study, Cancer Cell Study, Drug & Vaccine Study and Identification & Authentication Study), By End User (Veterinary Research Centres and Veterinary Hospitals & Diagnostic Labs), By Region (North America, Europe, Asia Pacific, MEA, CSA); End User Landscape, Vendor Landscape, and Company Market Share Analysis & Competitor Analysis
Mammalian Single Cell Analysis Market Insights
The global mammalian single cell analysis market is estimated to witness a significant growth during the forecast period (2020-2026). This market is expected to grow at a CAGR of ~22.5% during the forecast period. The market for mammalian cells will be growing in the coming years mainly due to advent or launch of single cell RNA sequencing of mammalian cells followed by advances in the single cell manipulation and amplification techniques for animal research, rising government funding for animal cell research amid COVID-19 pandemic, increasing number of biotechnology and biopharmaceutical companies, and immense applications of single-cell analysis in drug and vaccine research. Moreover, increasing research activities in the field of recombinant therapeutic protein, gene therapy, bio pesticides, monoclonal antibodies, microfluidics, cancer drugs and antiviral drugs have stimulated the growth of the market for animal cell analysis. Another major factor for the growth of the market could be the increasing interest in the study of animal identification and authentication which includes research work on animal cell culture, cell lines, cell viability, and characterization of cell lines. Also, nowadays, mammalian cell culture is a mandate step in order to manufacture biological therapeutics such as antibodies, interferon, hormones, clotting factors, and vaccines.
Mammalian Single Cell Analysis Market Size: By Component
On the basis of component, the market is segmented into instruments, consumables & reagents, and related software. The instruments segment is further segmented into NGS systems, flow cytometer, PCR, Spectrophotometer, Microarray and other instruments, the NGS systems will be the fastest growing market during the forecast period. NGS-based techniques have been a priority choice for the study of genomics, epigenetics and transcriptomics for focusing on the characterization of individual mammalian cells. However, as per the major segment, the consumables and reagents segment will hold the largest share in the market. The wide applications in research and genetic exploration, animal cell analysis, and isolation of RNA and DNA, and frequent purchase of the consumables and reagents as compared to a one-time investment instruments will help the consumables and reagents market grow.
Mammalian Single Cell Analysis Market: By Application
On the basis of application, the mammalian single cell analysis market is segmented into on cell interaction study, toxicity study, gene therapy study, cancer cell study, drug and vaccine study and identification and authentication study. Drug and vaccine study will grow fastest than other segment during the forecast period. Vaccination is one of the prime research area amid COVID-19 pandemic. Moreover, in the past with the help of the vaccine study, scientists have successfully eradicated smallpox, polio and great reductions in diseases such as whooping cough, measles, diphtheria, tetanus and hepatitis B among others. Hence the drug and vaccine testing & development on mammalian cells to understand the vaccine response, genetic combination of the virus, and after effects of drug induction will be increased than before.
Mammalian Single Cell Analysis Market: By End User
On the basis of end user, the market is segmented into veterinary research centres and veterinary hospitals & diagnostic labs. The veterinary research centres will account for the largest share in the market owing to factors such as growth in funding for life science research related to COVID-19 study and the increasing number of cases of infectious diseases which is leading to increasing research activities, will drive the growth of this end-user segment.
Mammalian Single Cell Analysis Market: By Region
Based on the region, the market is segmented into North America, Asia-Pacific, Europe, Middle East and Africa and Central & South America. North America is expected to dominate the market during the forecast period. This is due to rising focus and awareness of the American research institutes on the single cell RNA sequencing of mammalian cells using advanced technologies like NGS and PCR, followed by rising government funding for animal cell research amid COVID-19 pandemic, increasing number of launches of biotech and pharmaceutical research companies. Furthermore, Asia-Pacific region is expected to grow at a high CAGR during the forecast period. Factors such as presence of a large patient population of COVID-19 and other diseases in places like China and India, increasing investments in R&D, and rising trend of outsourcing clinical research to Asian CROs will help the Asian market for mammalian single cell analysis grow.
Mammalian Single Cell Analysis Market Share and Competitor Analysis
The key players operating in the market include: Becton, Dickinson and Company, Danaher Corporation, Merck Millipore, Qiagen N.V., Thermo Fisher Scientific, Inc., General Electric Company, 10x Genomics, Promega Corporation, Illumina, Inc., Bio-Rad Laboratories, Inc. and Fluidigm Corporation among others. (Other companies include Agilent Technologies, Inc., Nanostring Technologies, Inc., Tecan Group Ltd., Sartorius AG, Luminex Corporation, Takara Bio Inc., Fluxion Biosciences, Menarini Silicon Biosystems, Lumacyte, BD Biosciences, Silicon Biosystems, Sigma Aldrich and Novogene Corporation).
Please note: This is not an exhaustive list of companies profiled in the report.
In August 2020, the University of California (U.S.), conducted a research study with an aim to do genomic analysis using NGS sequencing technique for comparing the structure of the ACE2 receptor protein (the entry point of novel coronavirus) in ~410 different species of mammals, birds, fish, amphibian etc.
In July 2020, a U.S. based pharmaceutical company Heat Biologics, successfully conducted a study of pre-clinical testing of COVID-19 drug on animal lung cells. The studies included understanding of single T-cell reaction on selected vaccine that may be appropriate for human testing.
Related Report: Global Single-Cell Analysis Market Size, Trends & Analysis - Forecasts To 2026
Check the Press Release on Global Mammalian Single Cell Analysis Market Report
Mammalian Single Cell Analysis Market: By Components
Mammalian Single Cell Analysis Market: By Application
Mammalian Single Cell Analysis Market: By End User
Mammalian Single Cell Analysis Market: By Region
The global Mammalian Single Cell Analysis Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Mammalian Single Cell Analysis Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS